✦ LIBER ✦

Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis

✍ Scribed by Dr Ann Cranney, Jonathan D. Adachi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Raloxifene maintains BMD in postmenopaus

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Raloxifene reduces risk of cardiovascula

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 134 KB

Assessment of adherence to treatment of

✍ Itsuo Gorai; Yaku Tanaka; Shin Hattori; Yasuhisa Iwaoki 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 384 KB

Comparison of alendronate and raloxifene

✍ Sanad, Z.; Ellakwa, H.; Desouky, B. 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 527 KB

Raloxifene prevented new vertebral fract

✍ Robert D. Blank 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Risk Factors in Postmenopausal Osteoporo

✍ Escobar, S.A. Cuervo; Perez, Y.A. Umãna; Escobar, P. Cuervo; de Gómez, M. Sánche 📂 Article 📅 1985 🏛 The Lancet 🌐 English ⚖ 494 KB